Stock-Based Compensation (Tables)
|
9 Months Ended |
Mar. 31, 2017 |
|---|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] |
AntriaBio has computed the fair value of all options granted during the nine months ended March 31, 2017 using the following assumptions: | Expected volatility | | | 74% - 80 | % | | Risk free interest rate | | | 1.46% - 2.43 | % | | Expected term (years) | | | 7 | | | Dividend yield | | | 0 | % | AntriaBio has computed the fair value of all options granted during the year ended June 30, 2016 using the following assumptions: | Expected volatility | | | 97% - 100 | % | | Risk free interest rate | | | 1.69% -1.91 | % | | Expected term (years) | | | 7 | | | Dividend yield | | | 0 | % |
|
| Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] |
Stock option activity is as follows: | | | | | | Weighted | | | Weighted Average | | | | | Number of | | | Average | | | Remaining | | | | | Options | | | Exercise Price | | | Contractual Life | | | Outstanding, June 30, 2015 | | | 8,702,418 | | | $ | 2.78 | | | | 7.1 | | | Granted | | | 285,000 | | | $ | 1.07 | | | | | | | Forfeited | | | (40,000) | | | $ | 1.66 | | | | | | | Outstanding, June 30, 2016 | | | 8,947,418 | | | $ | 2.73 | | | | 6.2 | | | Granted | | | 24,275,000 | | | $ | 1.20 | | | | | | | Forfeited | | | (63,021) | | | $ | 1.15 | | | | | | | Outstanding, March 31, 2017 | | | 33,159,397 | | | $ | 1.61 | | | | 8.6 | | | | | | | | | | | | | | | | | Exercisable at March 31, 2017 | | | 6,946,771 | | | $ | 2.73 | | | | 5.4 | |
|
| Schedule Of Warrants Issued To Agents Activity [Table Text Block] |
Warrants- AntriaBio issued warrants to agents in conjunction with the closing of various financings and issued warrants in private placements as follows: | | | | | | Weighted | | | Weighted Average | | | | | Number of | | | Average | | | Remaining | | | | | Warrants | | | Exercise Price | | | Contractual Life | | | Outstanding, June 30, 2015 | | | 19,016,391 | | | $ | 2.33 | | | | 3.0 | | | Warrants issued in stock conversion | | | 5,897,677 | | | $ | 1.65 | | | | | | | Warrants issued in private placements | | | 3,043,669 | | | $ | 1.65 | | | | | | | Warrants issued to placement agents | | | 933,639 | | | $ | 1.61 | | | | | | | Warrants issued for investor relations | | | 103,000 | | | $ | 1.60 | | | | | | | Warrants cancelled | | | (30,000) | | | $ | 3.44 | | | | | | | Outstanding, June 30, 2016 | | | 28,964,376 | | | $ | 2.11 | | | | 3.1 | | | Warrants issued in private placements | | | 3,248,184 | | | $ | 1.65 | | | | | | | Warrants issued to placement agents | | | 536,150 | | | $ | 1.65 | | | | | | | Warrants issued for consulting services | | | 250,000 | | | $ | 1.00 | | | | | | | Warrants expired | | | (307,261) | | | $ | 2.34 | | | | | | | Outstanding, March 31, 2017 | | | 32,691,449 | | | $ | 1.73 | | | | 3.9 | |
|
| Black Scholes Pricing Model |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block] |
The Black-Scholes valuation methodology was used because that model embodies all of the relevant assumptions that address the features underlying these instruments. Significant assumptions for the warrants issued for the nine months ended March 31, 2017 were as follows: | Expected volatility | | | 24% - 111 | % | | Risk free interest rate | | | 0.45% - 1.56 | % | | Warrant term (years) | | | 0 - 7 | | | Dividend yield | | | 0 | % | Significant assumptions for the warrants issued for the year ended June 30, 2016 were as follows: | Expected volatility | | | 87 - 151 | % | | Risk free interest rate | | | 0.45% - 2.03 | % | | Warrant term (years) | | | 1 - 7.5 | | | Dividend yield | | | 0 | % |
|